Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
Clinical trial NCT02044653 · COMPLETED
Trial details
- NCT number
- NCT02044653
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-15
- Primary completion
- 2017-04-20
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.